All In MedTech

Device Trial Radar · NCT02712398

A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair

A Prospective, Multi-center Trial of a Long-term Bio-Absorbable Mesh With Sepra Technology in Challenging Laparoscopic Ventral or Incisional Hernia Repair

Last checked: Nov 19, 2026Latest source record: Jan 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

120

Actual

Start

Apr 2016

Primary completion

Nov 15, 2019

Study completion Nov 15, 2019

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
First posted
Mar 18, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to collect additional data on safety, performance and effectiveness of Phasix™ ST in subjects receiving laparoscopic ventral or incisional hernia repair at high risk for surgical site occurrence (SSO).

Conditions

  • Hernia, Ventral
  • Incisional Hernia

Interventions

  • Phasix™ STDevice

    Phasix™ ST is a fully resorbable mesh with a hydrogel coating that is also resorbable.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical Site Occurrence RateTime frame: 45 Days

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Yale-New Haven Medical Center

    New Haven, Connecticut

  • Florida Hospital

    Celebration, Florida

  • Emory University

    Atlanta, Georgia

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.